Clinical trial
N2000-01: Double Infusion of Iodine I 131 Metaiodobenzylguanidine Followed by…
NCT00083135 · Children's Hospital Los Angeles, Other · Completed
Key facts
| NCT number | NCT00083135 |
|---|---|
| Title | N2000-01: Double Infusion of Iodine I 131 Metaiodobenzylguanidine Followed by Autologous Stem Cell Transplantation |
| Official title | I-MIBG Escalating Dose Rapid Sequence Double Infusion Followed By Autologous Stem Cell Infusion For Refractory Neuroblastoma |
| Lead sponsor | Children's Hospital Los Angeles, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Neuroblastoma |
| Intervention type | Biological, Procedure, Radiation |
| Interventions | filgrastim, autologous bone marrow transplantation, peripheral blood stem cell transplantation, iobenguane I 131 |
| Enrollment | 18 |
| Start date | Mar 1, 2004 |
| Primary completion | Feb 1, 2006 |
| First posted | May 17, 2004 |
| Last update posted | Oct 15, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: